REQUEST A DEMO
Total
USD $0.00
Search more companies

Svanvid Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical and Medicine Manufacturing | All Other Miscellaneous General Purpose Machinery Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | All Other Professional, Scientific, and Technical Services | Educational Services | Repair and Maintenance
Full name: Svanvid Sp. z o.o. Profile Updated: May 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Svanvid Sp. z o.o. is a company in Poland, with a head office in Gdansk. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on February 04, 2014. Svanvid Sp. z o.o. currently employs 6 - 20 (2014) people.

Headquarters
Ul. Starodworska 1
Gdansk; Pomorskie; Postal Code: 80-137

Contact Details: Purchase the Svanvid Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Svanvid Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Svanvid Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Svanvid Sp. z o.o. report to view the information.
Incorporation Date:
February 04, 2014
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50.98%
Company Performance
Financial values in the chart are available after Svanvid Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
34.61%
EBITDA
34.61%
Net Profit/Loss for the Period
34.61%
Total Equity
-79.13%
Return on Equity (ROE)
-76.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?